Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Rachel C Myles, MBBS, PhD 0141 451 6121
Rachel.Myles@glasgow.ac.uk


Caroline J Coats, MBBS, PhD 0141 451 6121
Caroline.Coats@glasgow.ac.uk


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH)

Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH)

Recruiting

Open to: ALL

Age: 10.0 - N/A

Medical Conditions

Cardiomyopathies
Genetic Predisposition to Disease


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Genetic cardiomyopathy is increasingly recognised and can lead to heart failure, arrhythmia and sudden cardiac death. Some gene positive patients have rapidly progressive disease with high rates of heart failure and cardiac transplantation, while others present with SCD. Other gene positive patients will never develop cardiomyopathy. At present, we cannot distinguish between these groups and rely on expensive and labour-intensive surveillance by electrocardiography, echocardiography and sometimes cardiac magnetic resonance imaging.

This study will investigate existing and novel biomarkers (including blood, urine electrocardiographic and imaging) at various stages of disease in patients with a personal or family history of TTN, MYBPC3, LMNA, FLNC or DSP gene variant, which are known to cause cardiomyopathy.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Jun 2024 Mar 2027

OBSERVATIONAL

Intervention Type : DIAGNOSTIC_TEST
Intervention Description : This study will investigate existing and novel biomarkers (including blood, urine electrocardiographic and imaging) at various stages of disease in patients with a personal or family history of TTN, MYBPC3, LMNA, FLNC or DSP gene variant, which are known to cause cardiomyopathy.

Cardiomyopathy will be defined per European Society of Cardiology cardiomyopathy guidelines and heart failure stage will be defined per American Heart Associate guidelines.

Intervention Arm Group : Gene negative controls (family history of TTN, MYBPC3, LMNA, FLNC or DSP gene variant);Gene positive participants (personal history of TTN, MYBPC3, LMNA, FLNC or DSP gene variant);



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Queen Elizabeth University Hospital
    Glasgow
    G51 4TF

Rachel C Myles, MBBS, PhD 0141 451 6121
Rachel.Myles@glasgow.ac.uk


Caroline J Coats, MBBS, PhD 0141 451 6121
Caroline.Coats@glasgow.ac.uk



The study is sponsored by NHS Greater Glasgow and Clyde and is in collaboration with University of Glasgow; Roche Diagnostics GmbH.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT06446271
Last updated 01 July 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.